Our Solutions

Three Laboratories — One Vision  


Podcast with Dr. Lynne Le Sauteur

In this podcast, we sit down with Dr. Lynne Le Sauteur to discuss Altasciences’ laboratory vision. When we share knowledge, data, and innovation between groups and stages as your project advances, you benefit from data-driven decision making, from inquiry to completion. Listen in as Dr. Le Sauteur describes a real-life case study on Altasciences conducting a small molecule, Phase I study identifying novel metabolites. 

Podcast Lynne Le Sauteur

Listen to podcast

Dr. Le Sauteur received her PhD in Pharmacology and Therapeutics from McGill University and has over 20 years’ experience in biologic drug development.  As Vice President of Laboratory Sciences, Dr. Le Sauteur leads over 260 experts specialized in bioanalysis, ligand binding assays, mass spectrometry, immunology, biomarkers, and PCR. Altasciences’ bioanalytical laboratories are located in Laval, Canada, and Seattle, U.S.A., and its team has over 25 years of scientific and QA experience, delivering world-leading science, proven data integrity and global regulatory expertise to support both small and large molecule programs.

For access to all our podcasts and webinars, click here.

Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining solutions, whether a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.

You may also be interested in the following:
The Altascientist: Safety Pharmacology Guidelines and Practices
Webinar: Quantitation of Passive Immunotherapeutic Agents 
Scientific Poster: Assessment of Receptor Occupancy via Flow Cytometry


Our deep expertise and capabilities in a broad range of therapeutic areas encompasses preclinical and early clinical studies for both small molecules and biologics. We can manage your entire program, as well as provide comprehensive support research services and bioanalytical expertise.


Learn More

Working as a flexible, attentive extension of your team, we offer comprehensive drug development services to move your molecule forward.

Sign up for exclusive content

Join our list of 10,000+ VIP members and have access to our exclusive content.

You can unsubscribe at any time. For more details, please review our privacy policy.

Stay connected